Crown Laboratories Acquires Bellus Medical, Completes Commercial Integration Plan

January 21, 2020

Crown Laboratories has announced that it has restructured its commercial operations business units as it continues to elevate its new “Skin Science for Life” commitment. For the past two years, Crown has been dedicated to transforming its Northeast Tennessee operations into a leading global skin care company. After acquiring its Beauty and Aesthetic divisions (formerly Vita Liberata and Bellus Medical, respectively) and strengthening its therapeutics portfolio through the acquisition of six consumer heritage brands from GlaxoSmithKline, Crown is now poised to become a global leader in dermatology health and wellness.
Read more at PR Newswire >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • FDA Moves to Reevaluate Several Peptides
    • Massachusetts Med Spa Owner Pleads Guilty in Federal Counterfeit Injection Case
    • Merz Aesthetics’ Radiesse Receives FDA Approval for Décolleté Wrinkles
    • New Book “Get Found, Get Booked” Reveals a Smarter, Ethical Approach to Marketing for Med Spas and Wellness Practices
    • Bill Regulating Indiana Med Spas Has Passed: What You Need to Know and Why Collective Advocacy Matters